Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Check the spelling in your query or search for a new term.
Site search accepts advanced operators to help refine your query. Learn more.
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
This open source dataset contains over 290K structure-activity relationship (SAR) data directed at COVID-19 protein, virus and disease targets reported in the literature, patents, and other public sources for over 9K of the substances included in the CAS COVID-19 Antiviral Candidate Compounds Dataset.
The CAS Covid-19 dataset has been extracted from the CAS REGISTRY® including known anti-viral drugs and related chemical compounds that are structurally similar to known antivirals and is subject to these license terms.
With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.
Download this CAS whitepaper and learn five often overlooked IP gaps that can hinder innovation strategy.
This CAS white paper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.
This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.
Are you just getting started or ramping up machine learning for chemical and materials research? In this webinar, the panelists will discuss how to prepare for a new informatics project by exploring how to build useful data sets, identify missing capabilities, and communicate expectations.
Request promotional materials for CAS SciFinderⁿ.
This white paper presents an analysis of the RAS inhibitor landscape, with views based on structural similarity, chemical properties, and patent assignees. See what the insights reveal.